TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · major macro event coming up
GRCL

Gracell Biotechnologies Inc.

Healthcare · Biotechnology

485.20$ -2.8% vs. previous close Closing price · As of: Aug 13, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet GRCL
Line item 2018 2019 2020 2021 2022
– +177.6% +134.1% +113.5% -19.6%
– +166.0% +139.6% +131.2% -20.7%
– +2,524.5% +141.7% +142.5% -20.5%
– +177.7% +144.4% +137.1% -20.4%
– +122.1% +124.8% +31.4% -35.3%
– +21.9% -429.9% – -402.7%
– +196.7% +146.4% +28.9% -5.7%
– +7.3% -7.4% +60.2% +20.5%
– +144.2% +413.9% +66.2% +42.2%
– – – +68.8% +51.1%
– – – – –
– +0.0% -62.6% +4.7% -14.4%
– +10,615.7% +221.0% +122.9% -24.7%
– – – – –
– +0.0% +231.0% +0.3% +2.9%

Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?